Sugi Predict

Sugi Predict / Compounds / SCHEMBL28334883

SCHEMBL28334883

SCHEMBL28334883

O=c1ccn([C@]2([C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ SLC28A1 O00337 1/20 0.52
▸ SLC28A2 O43868 1/20 0.52
▸ SLC29A1 Q99808 1/20 0.52
▸ SLC28A3 Q9HAS3 1/20 0.52
▸ P2RY14 Q15391 8/20 0.41
▸ P2RY2 P41231 6/20 0.39
▸ P2RY6 Q15077 5/20 0.39
▸ P2RY4 P51582 4/20 0.38
▸ PYGM P11217 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28404493 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL28447938 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL29041685 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL28988286 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL7189862 0.99 SLC28A1 (0.53) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL15453824 0.99 SLC28A1 (0.53) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL7183631 0.99 SLC28A1 (0.53) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL1801780 0.99 SLC28A1 (0.53) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL28732799 0.90 SLC28A1 (0.44) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL29178068 0.89 SLC28A1 (0.45) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118515779-A Anti-HK 2 Chimeric Antigen Receptor (CAR) 詹森生物科技公司 2024-08-20 — — CN disclosed
CN-118459611-A GPRC5D chimeric antigen receptors and cells expressing these receptors 詹森生物科技公司 2024-08-09 — — CN disclosed
CN-117580950-A Compositions and methods for treating TDP-43 proteinopathies 梅兹治疗公司 2024-02-20 — — CN disclosed
CN-113150112-B T cell receptor against human papilloma virus 16E7 美国卫生和人力服务部 2024-02-06 — — CN disclosed
CN-116802290-A Nucleic acids for inhibiting PROS1 expression in cells 伯尔尼大学 2023-09-22 — — CN disclosed
CN-116712540-A Treatment of gastrointestinal disorders using integrin inhibitors 比奥拉治疗股份有限公司 2023-09-08 — — CN disclosed
CN-110167589-B Treatment of gastrointestinal disorders using integrin inhibitors 比奥拉治疗股份有限公司 2023-05-16 — — CN disclosed
CN-116036117-A Nucleic acids linked to trivalent glycoconjugates 赛伦斯治疗有限公司 2023-05-02 — — CN disclosed
CN-114206934-A Encapsulated protein-6 bispecific antibodies 加利福尼亚大学董事会 2022-03-18 — — CN disclosed
CN-114174340-A Encapsulated protein-6 antibodies and drug conjugates 加利福尼亚大学董事会 2022-03-11 — — CN disclosed
CN-113841078-A Methods, devices and systems for analyte detection and analysis 阿尔缇玛基因组学公司 2021-12-24 — — CN disclosed
CN-113164768-A Nucleic acids and iron chelators for inhibiting expression of TMPRSS6 赛伦斯治疗有限责任公司 2021-07-23 — — CN disclosed
CN-105792832-B Organic compounds for the treatment of hepatitis B virus 诺华股份有限公司 2021-03-23 — — CN disclosed
CN-107312777-B Antisense antiviral compounds and methods of treating influenza virus infection 萨雷普塔治疗公司 2020-11-13 — — CN disclosed
CN-111615425-A Methods and systems for analyte detection and analysis 阿尔缇玛基因组学公司 2020-09-01 — — CN disclosed
CN-107058059-B Efficient small volume nucleic acid synthesis 基因技术股份公司 2020-08-07 — — CN disclosed
CN-106659146-B Humanized C5 and C3 animals 再生元制药公司 2020-06-23 — — CN disclosed
CN-110573619-A Products and compositions 赛伦斯治疗有限责任公司 2019-12-13 — — CN disclosed